PD-0081 SBRT, Durvalumab+-Tremelimumab in metastatic SCC: preliminary safety results of a phase I/II trial
- Resource Type
- Source
- Radiotherapy and Oncology. 170:S57-S58
- Subject
Oncology Radiology, Nuclear Medicine and imaging Hematology - Language
- ISSN
- 0167-8140